Junel FE NDC 72189-215

NDC codes

FDA NDC Directory

Product NDC (as listed)72189-215Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72189-0215Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72189-215-28	72189021528	28 TABLET in 1 POUCH (72189-215-28)Marketed from Oct 6, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Junel FE
Generic name (nonproprietary): junel fe
Active ingredients: Ethinyl estradiol — 20 ug/1Norethindrone acetate — 1 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Direct_Rx
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076380
Marketing start: Oct 6, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Estrogen Receptor Agonists (Mechanism)Progesterone Congeners (Chemical structure)
Identifiers: Product ID 72189-215_4d3a9c67-ae9a-d4c1-e063-6394a90aff1fSPL ID 4d3a9c67-ae9a-d4c1-e063-6394a90aff1fSPL set ID ea62a66e-d45d-11be-e053-2a95a90a7801RxCUI 1358762UNII 423D2T571U, 9S44LIC7OJ
Pharmacologic class: Estrogen; Progestin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472189021528 followed by a unit qualifier and the quantity

Package 72189-0215-28. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 17, 2026.

Indications (excerpt from the label)

Junel21 and Junel Fe 28 are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective. Table I lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. TABLE I: LOWEST EXPECTED AND TYPICAL FAILURE RATES DURING THE FIRST YEAR OF CONTINUOUS USE OF A METHOD % Of Women Experiencing an Unintended Pregnancy in the First Year of Continuous …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 076380

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076380
Product	Strength	Form · route	Labeler	Product NDC
Junel 21 Daynorethindrone acetate and ethinyl estradiol	Norethindrone acetate 1 mg/1; Ethinyl estradiol 20 ug/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0555-9025
Junel 21 Daynorethindrone acetate and ethinyl estradiol	Norethindrone acetate 1 mg/1; Ethinyl estradiol 20 ug/1	TabletOral	Proficient Rx LP	82804-172
Loestrin 21 Daynorethindrone acetate and ethinyl estradiol	Norethindrone acetate 1 mg/1; Ethinyl estradiol 20 ug/1	TabletOral	Teva Women's Health LLC	51285-131